PCI Biotech appoints Dr Amir Snapir as Chief Medical Officer
March 31, 2020 02:00 ET
|
PCI Biotech Holding ASA
Oslo, Norway, 31 March 2020 - PCI Biotech announces the appointment of Dr Amir Snapir, MD, PhD as Chief Medical Officer (CMO). Dr Snapir will also serve as a member of PCI Biotech’s executive...
PCI Biotech: US patent for the vaccine technology (fimaVacc) with a new important class of adjuvants
March 26, 2020 04:12 ET
|
PCI Biotech Holding ASA
Oslo (Norway), 26 March 2020 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, today announces that the U.S. Patent and Trademark Office (USPTO) has informed the company that a...
PCI Biotech: Update on operational implications of the corona pandemic
March 25, 2020 05:06 ET
|
PCI Biotech Holding ASA
Oslo, Norway, 25 March, 2020: PCI Biotech (OSE: PCIB) has closely monitored potential implications on its short- and long-term operations following the latest development of the coronavirus pandemic....
PCI Biotech's fourth quarter and preliminary 2019 results
February 26, 2020 01:00 ET
|
PCI Biotech Holding ASA
Oslo (Norway), 26 February 2020 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, today announces its interim fourth quarter and preliminary 2019 results. Please find enclosed the...
PCI Biotech: Invitation to fourth quarter and preliminary 2019 results presentation
February 19, 2020 07:38 ET
|
PCI Biotech Holding ASA
Oslo, Norway, 19 February 2020 - PCI Biotech invites to a presentation of the company's fourth quarter and preliminary 2019 results on Wednesday 26 February 2020 at Oslo Cancer Cluster Innovation...
PCI Biotech: US patent granted for the vaccine technology (fimaVacc) in combination with cytokines
January 21, 2020 02:00 ET
|
PCI Biotech Holding ASA
Oslo (Norway), 21 January 2020 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, today announces that the U.S. Patent and Trademark Office (USPTO) has granted the company a US...
PCI Biotech to present Phase I fimaVacc results at ESMO Immuno-Oncology 2019
December 12, 2019 02:00 ET
|
PCI Biotech Holding ASA
Oslo, Norway, December 12, 2019 PCI Biotech (OSE:PCIB), a clinical-stage company developing innovative therapeutics that address significant unmet medical needs, today announced that it will present...
PCI Biotech: Third quarter 2019 results
November 27, 2019 01:00 ET
|
PCI Biotech Holding ASA
Oslo (Norway), 27 November 2019 - PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company today announces its third quarter 2019 result. Please find enclosed the report and presentation. ...
PCI Biotech: Expansion of preclinical research collaboration agreement with AstraZeneca
November 26, 2019 12:10 ET
|
PCI Biotech Holding ASA
Oslo (Norway), 26 November 2019 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, today announced an expansion of its preclinical research collaboration with AstraZeneca. The...
PCI Biotech to present at Jefferies 2019 London Healthcare Conference
November 19, 2019 09:00 ET
|
PCI Biotech Holding ASA
Oslo, Norway, November 19, 2019 PCI Biotech (OSE:PCIB), a late stage clinical company developing innovative therapeutics that address significant unmet medical needs, today announced that it will...